Liver disease, creatinine clearance, and aminoglycoside nephrotoxicity.
D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003404:Creatinine / Q000378:metabolism*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008107:Liver Diseases / Q000378:metabolism*; D008657:Metabolic Clearance Rate
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003404:Creatinine